Naproxen Sodium/Metoclopramide Hydrochloride

萘普生钠/盐酸甲氧氯普胺

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNaproxen Sodium/Metoclopramide Hydrochloride
Drug Alias Name盐酸甲氧氯普胺/萘普生钠Metoclopramide Hydrochloride/Naproxen SodiumMetoclopramide/Naproxen SodiumNaproxen sodium/metoclopramideMT-100
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsDopamine receptors antagonists
TargetsDopamine receptorsCyclooxygenases
Therapy Area/IndicationsMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes NaproxenMetoclopramide Hydrochloride
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesAralez Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAralez Pharma
Active IndicationsN/A
Inactive IndicationsMigraine Disorders

Other Information

ATC CodeN/A
Related LinksN/A